Scandion Oncology A/S

OM:SCOL BTA Stock Report

Market Cap: SEK 240.2m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Scandion Oncology Management

Management criteria checks 0/4

Key information

Bo Hansen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.8yrs
CEO ownership0.1%
Management average tenureless than a year
Board average tenure1.2yrs

Recent management updates

No updates

Recent updates

No updates


CEO

Bo Hansen

1.8yrs

Tenure

Dr. Bo Rode Hansen, Msc, Ph D, serves as Vice President of Alliance Management & Partnered Drug Discovery at Roche Innovation Center Copenhagen A/S. Dr. Hansen serves as Director at Scandion Oncology A/S s...


Leadership Team

NamePositionTenureCompensationOwnership
Nils Brünner
Co-Founder & Scientific Advisorno datano datano data
Bo Hansen
President1.8yrsno data0.10%
SEK 250.4k
Johnny Stilou
Chief Financial Officerless than a yearno data0.025%
SEK 59.0k
Maj Hedtjarn
COO and Head of R&D Operations1.3yrsno data0.059%
SEK 141.6k
Morten Nissen
General Counselno datano datano data
Mads Kronborg
Head of External Communicationless than a yearno datano data
Annie Rasmussen
Chief Clinical Officer & Employee Representative Directorless than a yearno data0.049%
SEK 118.0k
Alfredo Zurlo
Chief Medical Officerless than a yearno datano data

0.7yrs

Average Tenure

Experienced Management: SCOL BTA's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Nils Brünner
Co-Founder & Scientific Advisor1.3yrsno datano data
Bo Hansen
President2.2yrsno data0.10%
SEK 250.4k
Annie Rasmussen
Chief Clinical Officer & Employee Representative Director2.5yrsno data0.049%
SEK 118.0k
Jorgen Vilhelm Bardenfleth
Independent Vice-Chairman of the Board4.5yrsno data1.05%
SEK 2.5m
Palle Christophersen
Member of Scientific Advisory Boardno datano datano data
Richard Schilsky
Member of Clinical Advisory Board1.3yrsno datano data
Eric Cutsem
Member of Clinical Advisory Boardless than a yearno datano data
Josep Tabernero
Member of Clinical Advisory Boardless than a yearno datano data
Susan Bates
Member of Scientific Advisory Boardno datano datano data
Keld Jorgensen
Independent Directorless than a yearno datano data
Thomas T. Seufferlein
Member of Clinical Advisory Boardless than a yearno datano data
Martin Moller
Independent Chairman of the Board1.2yrsno data0.012%
SEK 27.7k

1.2yrs

Average Tenure

64.5yo

Average Age

Experienced Board: SCOL BTA's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.